External Source

Tkis To Treat Egfrm-positive Nsclc

2019 2:03
Synopsis
Marina Garassino, MD, of National Cancer Institute of Milan, Milan, Italy, discusses the current treatment options for non-small cell ...

You Might Also Like

Understanding NSCLC Treatment When You Have an EGFR Mutation 5:03
Understanding Nsclc Treatment When You Have An Egfr Mutation
2024
EGFR TKIs for Upfront Treatment of NSCLC 5:47
Egfr Tkis For Upfront Treatment Of Nsclc
2016
Patterns of Acquired Resistance to EGFR TKIs in EGFR Mutation-Positive NSCLC 2:26
Patterns Of Acquired Resistance To Egfr Tkis In Egfr Mutatio...
2017
EGFR TKIs Excite Treatment Landscape of EGFR-Mutant Lung Cancers 1:24
Egfr Tkis Excite Treatment Landscape Of Egfr-mutant Lung Can...
2020
Afatinib for advanced EGFRm-positive NSCLC 1:35
Afatinib For Advanced Egfrm-positive Nsclc
2019
Macrocyclic TKIs in Treatment-Naïve and Pretreated Fusion-Positive NSCLC and Other Tumors 28:43
Macrocyclic Tkis In Treatment-naïve And Pretreated Fusion-p...
2022
Second- and Third-Generation TKIs in EGFR-Mutated NSCLC 2:36
Second- And Third-generation Tkis In Egfr-mutated Nsclc
2019
Targeted treatment with EGFR TKIs: Front line options 20:24
Targeted Treatment With Egfr Tkis: Front Line Options
2018
Ramucirumab Used to Delay Relapse Following EGFR TKIs in EGFR+ NSCLC 2:10
Ramucirumab Used To Delay Relapse Following Egfr Tkis In Egf...
2019
Treatment Options for EGFR-positive Lung Cancer 1:59
Treatment Options For Egfr-positive Lung Cancer
2021
Dr. Clarke on Available EGFR TKIs in Frontline Treatment of EGFR+ NSCLC 1:52
Dr. Clarke On Available Egfr Tkis In Frontline Treatment Of ...
2019
Download Options
Choose a download method below. All links open in new tabs.
Service Features Action
SaveFrom
MP4 & MP3 • HD Quality • Browser Extension Available
Download
Security Notice: These are third-party services. We recommend using antivirus software and being cautious of pop-up ads.